Cargando…
Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects
Identifying effective therapeutic treatment strategies is a major challenge to improving outcomes for patients with breast cancer. To gain a comprehensive understanding of how clinically relevant anti-cancer agents modulate cell cycle progression, here we use genetically engineered breast cancer cel...
Autores principales: | Gross, Sean M., Mohammadi, Farnaz, Sanchez-Aguila, Crystal, Zhan, Paulina J., Liby, Tiera A., Dane, Mark A., Meyer, Aaron S., Heiser, Laura M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257663/ https://www.ncbi.nlm.nih.gov/pubmed/37301933 http://dx.doi.org/10.1038/s41467-023-39122-z |
Ejemplares similares
-
A lineage tree-based hidden Markov model quantifies cellular heterogeneity and plasticity
por: Mohammadi, Farnaz, et al.
Publicado: (2022) -
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
por: Smith, Rebecca, et al.
Publicado: (2020) -
INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer
por: Liu, Moqing, et al.
Publicado: (2022) -
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes
por: Watson, Spencer S., et al.
Publicado: (2018) -
MOBILE pipeline enables identification of context-specific networks and regulatory mechanisms
por: Erdem, Cemal, et al.
Publicado: (2023)